We are live on ! Find out more
ACIU icon

AC Immune

53 hedge funds and large institutions have $99.7M invested in AC Immune in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

53% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $792K

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

26% more funds holding

Funds holding: 4253 (+11)

0.47% more ownership

Funds ownership: 28.37%28.83% (+0.47%)

27% less capital invested

Capital invested by funds: $137M → $99.7M (-$37.5M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
53
Holders Change
+11
Holders Change %
+26.19%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
16
Reduced
12
Closed
5
Calls
$1.22M
Puts
$792K
Net Calls
+$423K
Net Calls Change
+$423K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$1K +$1.36K +189 New
D.E. Shaw & Co
52
D.E. Shaw & Co
New York
-$223K -33,159 Closed
Marshall Wace
53
Marshall Wace
United Kingdom
-$181K -26,770 Closed
Two Sigma Advisers
54
Two Sigma Advisers
New York
-$101K -14,944 Closed
Lazard Asset Management
55
Lazard Asset Management
New York
-$38K -5,741 Closed
Russell Investments Group
56
Russell Investments Group
United Kingdom
-$17K -2,652 Closed
ASN
57
Advisory Services Network
Georgia
+$29 +4 New
Simplex Trading
58
Simplex Trading
Illinois
+$63.3K +8,821 New

ACIU Hedge Fund Activity: Q3 2020 in Review

53 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2020, worth a combined $99.7M — down 27% from $137M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ACIU positions and 5 closed out — a net gain of 11 holders — while 16 added to existing stakes and 12 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $11.1M. The largest seller was BVF Inc, cutting an estimated $10.8M.

  • 53 institutional investors held AC Immune (ACIU) as of Q3 2020, up from 42 in Q2 2020.
  • Funds reported $99.7M of AC Immune stock for Q3 2020, down 27% quarter-over-quarter.
  • 16 funds opened new AC Immune positions in Q3 2020 and 5 closed out, a net change of +11 holders.
  • The largest AC Immune buyer in Q3 2020 was Avidity Partners Management, an estimated $11.1M added.
  • The largest AC Immune seller in Q3 2020 was BVF Inc, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2020.